Neuro-oncology

METABOLIC IMAGING BIOMARKERS FOR MUTANT IDH1 GLIOMAS.

Neuro-oncology

Sabrina M. Ronen, Jose L. Izquierdo-Garcia, Myriam M. Chaumeil, Larry M. Cai, Joanna J. Phillips, Russell O. Pieper

METABOLIC IMAGING BIOMARKERS FOR MUTANT IDH1 GLIOMAS.

Neuro-oncology

Sabrina M. Ronen,Jose L. Izquierdo-Garcia,Myriam M. Chaumeil,Larry M. Cai,Joanna J. Phillips,Russell O. Pieper

The epidemiology of glioma in adults: a "state of the science" review.

Neuro-oncology

Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS

A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma.

Neuro-oncology

Clarke JL, Molinaro AM, Phillips JJ, Butowski NA, Chang SM, Perry A, Costello JF, DeSilva AA, Rabbitt JE, Prados MD

The epidemiology of glioma in adults: a "state of the science" review.

Neuro-oncology

Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS

A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma.

Neuro-oncology

Clarke JL, Molinaro AM, Phillips JJ, Butowski NA, Chang SM, Perry A, Costello JF, DeSilva AA, Rabbitt JE, Prados MD

Lactate dehydrogenase A silencing in IDH mutant gliomas.

Neuro-oncology

Chesnelong C, Chaumeil MM, Blough MD, Al-Najjar M, Stechishin OD, Chan JA, Pieper RO, Ronen SM, Weiss S, Luchman HA, Cairncross JG

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.

Neuro-oncology

Bloch O, Crane CA, Fuks Y, Kaur R, Aghi MK, Berger MS, Butowski NA, Chang SM, Clarke JL, McDermott MW, Prados MD, Sloan AE, Bruce JN, Parsa AT

Pages